H

Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627

Watchlist Manager
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
Watchlist
Price: 1.58 CNY Market Closed
Market Cap: 7.7B CNY

Intrinsic Value

The intrinsic value of one Hubei Biocause Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 1.58 CNY, Hubei Biocause Pharmaceutical Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Hubei Biocause Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Hubei Biocause Pharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Hubei Biocause Pharmaceutical Co Ltd looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if Hubei Biocause Pharmaceutical Co Ltd is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Hubei Biocause Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Hubei Biocause Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Hubei Biocause Pharmaceutical Co Ltd.

Explain Valuation
Compare Hubei Biocause Pharmaceutical Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Hubei Biocause Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hubei Biocause Pharmaceutical Co Ltd

Cash & Short-Term Investments 8.5B
Insurance Receivable 715m
PP&E 1.5B
Long-Term Investments 216.4B
Other Assets 58B
Insurance Policy Liabilities 240.5B
Long Term Debt 5.6B
Other Liabilities 17.3B

Wall St
Price Targets

Price Targets Summary
Hubei Biocause Pharmaceutical Co Ltd

There are no price targets for Hubei Biocause Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hubei Biocause Pharmaceutical Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Hubei Biocause Pharmaceutical Co Ltd stock?

The intrinsic value of one Hubei Biocause Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY.

Is Hubei Biocause Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 1.58 CNY, Hubei Biocause Pharmaceutical Co Ltd is hidden .

Back to Top